Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Contrary to opioids, which bind to µ-opioid receptors within the central nervous system, conolidine modulates alternate molecular targets. A Science Innovations review uncovered that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://edgarlrsuv.bloguetechno.com/helping-the-others-realize-the-advantages-of-alternative-natural-pain-relief-to-replace-traditional-painkillers-73668090